Blood Advances | 2024
CD19-directed CART therapy for T cell/histiocyte rich large B-cell lymphoma.
Pophali PA, Fein JA, Ahn KW, Allbee-Johnson M, Ahmed N, Awan FT, Farhan S, Grover NS, Hilal T, Iqbal M, Maakaron J, Modi D, Nasrollahi E, Schachter L, Sauter CS, Hamadani M, Herrera AF, Shouval R, Shadman M
PubMed
PMID: 38985302
Abstract
Related Articles
CIBMTR Study #: LY22-02b